In a general population without known liver disease, we tested whether: (a) increased liver fibrosis scores (FIB‐4 and APRI) are associated with liver cancer mortality and (b) the probability that… Click to show full abstract
In a general population without known liver disease, we tested whether: (a) increased liver fibrosis scores (FIB‐4 and APRI) are associated with liver cancer mortality and (b) the probability that a person with a higher score died of liver cancer.
               
Click one of the above tabs to view related content.